First-in-man clinical trial in S'pore for stem cell technology by SingHealth Duke-NUS AMC, Cordlife
(Duke-NUS Medical School) SingHealth Duke-NUS AMC and Cordlife partner to advance stem cell technology to first-in-man clinical trial in Singapore
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Singapore Health | Stem Cell Therapy | Stem Cells